At Heligenics, we produce all genetic variants for a given gene and test how all those variants functionally impact, en masse, live human cells.
We are the first company to analyze all mutations in a gene at once.
.png){kind=logo}
™
Meet the Team
Staff
Founder & CEO
Martin Schiller, Ph.D
-
31 years experience as Institute Director and Professor of functional genomics
-
>80 publications
-
Inventor of the GigaAssay
-
Responsible for general business and science decisions, day-to-day management, and scientific oversight
Head of Cell Engineering & Analysis
Liz Valente, Ph.D
-
15 years of experience in academic Cancer Cell Biology and CRISPR Screening
-
Responsible for Assay development, GigaAssays, Cell Culture, Flow Cytometry, and cell engineering
Head of Molecular Biology
Lancer Brown
-
20 years experience in industrial molecular biology, drug screening, and as a Chief Scientific Officer
-
Responsible for Assay development, building GML and NGS libraries
Bioinformatics
Christopher GiacolettoÂ
-
Accomplished Bioinformatician with 4 years of academic and industrial experience
-
Developer of MEGA-Maps pipeline
-
Responsible for building the pipeline, analyzing GigaAssay experiments, and building MEGA-Maps
Research Associate
Allison Stone
-
Molecular Biology associate
-
Responsible for building constructs and maintaining the laboratory
Research Associate
Brandon Murphy, Ph.D
-
Cell Culture associate
-
Responsible for cell line engineering, lentivirus production and cell culture
Operations Manager
Sandra Cardozo
-
34 years experience in management, advertising, sales, and academics
-
MBA, HRM, previous Dean
-
Responsible for operations management, HR and Finance
Board of Directors
Martin Schiller, Ph.D.
Martin Schiller
Chairman
​Martin has over 31 years of experience as Institute Director and Professor of Functional Genomics. He has published 90 research articles. He is the inventor of the GigaAssay. He is responsible for general business and science decisions, day-to-day management, and scientific oversight
Stan Schiller
Director
Stan has 60 years of sales and executive management experience. He has been a Sales Manager and COO. He is responsible for general business and operation decisions.
Jerome Rotter
Director
Chief Scientific Advisor
Jerry has 37 years of experience as a Director/Co-Director. He is a Pioneer in medical genetics and genomics of common diseases. He is a Medical Geneticist Physician. He has been an executive in 2 companies. He has published over 1,100 articles. He is responsible for scientific and business decision-making.
Naga Chalasani
Director
Â
Naga is a Pioneer in liver clinical and translational research, working on NASH, and iver and drug hepatotoxicity . He is a practicing gastroenterologist and hepatologist for over twenty five years at Indiana University in Indianapolis. He has published over 575 scientific articles. He is responsible for clinical and Biologic related decision-making in Heligenics.
Board of Advisors
Asa Lanum
Board Chair
Asa has over 45 years in business, technology, international executive, and operational experience, and has authored over 30 research papers and books. His specialty is in technology architecture and development and business process. His executive experience includes CEO, Board Chairman, Board Member, CIO, CTO, Managing Director, and Founder.
Darren Johnson
Board Member
Darren is a bio-pharmaceutical executive and analytics / optimization expert with over 20 years of experience. He has worked at Genentech / Roche, BioMarin, and Reata. Darren brings US and global expertise in commercial operations, business development, corporate strategy, market insights, product positioning, launch readiness, marketing, sales, supply chain, and operations to Heligenics.
Kris Govindadas
Board Member
Kris Govindadas has extensive experience in finance and has worked as CFO in various companies such as Heartland Food Products, Sara Lee Corporation, and Jimmy Dean Foods. Kris has also held the title of VP Finance in the retail food and beverage sector. Kris advises Heligenics on buisness strategy and financial matters.
Wayne Grody
Board Member
Wayne has been a leader in genetic diagnostics for 45 years. He has published over 280 publications. Wayne is the Director of the UCLA Genetics Lab. He is double Board Certified. Wayne is a Rare Disease expert. He was President of ACMG. Wayne advises Heligenic on Genetics and applications of and strategy for MEGA-Maps in medical genetics.
William (Bill) Botts
Board Member
Bill has over 56 years of experience in executive management and turnaround experience. He has served as Executive Advisor to several startups and early-stage companies anled private and public companies. He specializes in high technology and consumer products and has hands-on merger and acquisition experience. His executive experience includes Board Chairman, Board Member, CEO, President, and Founder.
David McCandless
Board Member
Dave has 30+ years of IT experience building solutions and transforming global organizations across multiple industries, most recently limaritime shipping, financial markets, enterprise software, oil, and telecommunications. His primary expertise is global IT service delivery, with a focus on cloud data and analytics to solve problems at scale. He has advisory board, lecturer, and outreach experience across industry, academic, and civic organizations.
Susan Mockus
Board Member
Susan has over 15 years of industry experience in business development, strategic alliances, and product innovation. Her technical areas of expertise include genomics, bioinformatics, and the interpretation of big data. She has led numerous commercial product launches across a wide variety of scientific translational applications.